Advanced Analytics

John Linnehan

“Deeply rooted in our clients' business, we identify relevant data analyses to work together to determine effective solutions.”

John Linnehan
Senior Vice President

Infusing Big Data with Expert Insights

Our robust proprietary data assets–the MORE2 Registry® and CMS Qualified Entity (QE) data–strengthen our methods by leveraging information from 40.1 billion medical events and 261 million unique patients. With in-house experts spanning economics, actuarial science, policy, market access and reimbursement, payment and delivery, and value-based care, we answer complex questions supported by patient data. Our predictive modeling can help you determine how health reforms and payment policies will impact your business financials. Manufacturers count on our statistical techniques and benchmarking to support product commercialization. And Congress relies on our analysis to weigh policy decisions. Together, we can take your business to the next level with facts and expert interpretation and guidance.

Customized Solutions

Whether you are from a life sciences company, plan, or provider, we have you covered.
Actuarial Science
Budget Impact & Cost-Effective Modeling
Comparative Analytics
Economic Modeling
Financial Modeling
Predictive Analytics
Real-World Data-Driven Insights
Study Design